FDA Inspection
Noven Pharmaceuticals IncNoven Pharmaceuticals Inc – FDA Inspection, Jan 26, 2018
Record Details
This FDA Inspection record concerns Noven Pharmaceuticals Inc, with an inspection on January 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Caroline Strasinger (Issuing Officer)
- Noreen Muniz (FDA Associated Person)
View Company Profile
ID · 89a15159-baea-4864-8230-2359b4c22210
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1040075
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Noven Pharmaceuticals Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2026 | Not classified | Florida District Office | Drug Quality Assurance |
| February 13, 2026 | Not classified | Florida District Office | |
| November 17, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Noven Pharmaceuticals Inc
- FDA Inspection 1319056 - 2026-08-24
- FDA Inspection 1285900 - 2026-02-13
- FDA Inspection 1156913 - 2021-11-17
- FDA Inspection 934846 - 2015-07-10
- FDA Inspection 800319 - 2012-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.